JX09 SAD/MAD in Healthy Participants
Phase 1
Recruiting
- Conditions
- Resistant Hypertension
- Interventions
- First Posted Date
- 2023-12-27
- Last Posted Date
- 2024-02-26
- Lead Sponsor
- Ji Xing Pharmaceuticals Australia Pty Ltd
- Target Recruit Count
- 92
- Registration Number
- NCT06183671
- Locations
- 🇦🇺
Nucleus Network Pty Ltd, Melbourne, Australia
© Copyright 2025. All Rights Reserved by MedPath